Loading…
Loading…
Bank of America Corp DE raised its stake in shares of Global X Genomics and Biotechnology ETF (NASDAQ: GNOM) by 67.8% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 119,795 shares of the company's stock after acquiring an additional 48,394 shares
Global X Genomics and Biotechnology ETF (NASDAQ: GNOM - Get Free Report)'s stock price passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $48.87 and traded as high as $59.96. Global X Genomics and Biotechnology ETF shares last traded at $59.72, with a volume of 15,583
The ARK Genomic Revolution ETF (CBOE:ARKG) and the Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) look like siblings on any screener.
IBB and other biotech ETFs are gaining traction as AI reshapes drug discovery, genomics, and clinical trials, giving investors diversified exposure to biotech innovation.
Comprehensive Money Management Services LLC decreased its position in shares of Global X Genomics and Biotechnology ETF (NASDAQ: GNOM) by 74.4% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,241 shares of the company's stock after selling 15,264 shares
Global X Genomics and Biotechnology ETF (NASDAQ: GNOM - Get Free Report)'s stock price passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $40.19 and traded as high as $48.00. Global X Genomics and Biotechnology ETF shares last traded at $47.83, with a volume of 10,635
Shares of Global X Genomics and Biotechnology ETF (NASDAQ: GNOM - Get Free Report) crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $37.63 and traded as high as $45.62. Global X Genomics and Biotechnology ETF shares last traded at $45.13, with a volume of 17,129
Wall Street was upbeat last week with the Dow Jones and the S&P 500 hitting all-time highs last week.